vimarsana.com
Home
Live Updates
China's Kelun Biotech snaps $581m at pre-money valuation of
China's Kelun Biotech snaps $581m at pre-money valuation of
China's Kelun Biotech snaps $581m at pre-money valuation of $871m
In April 2021, Kulun Biotech secured over $77m in a funding round led by CMC-SDIC Capital.
Related Keywords
China ,
United States ,
Shenzhen ,
Guangdong ,
Sichuan ,
Gansu ,
Chinese ,
American ,
,
Shenzhen Stock Exchange On ,
Kelun Biotech ,
Shenzhen Listed Kelun Pharmaceutical ,
Shenzhen Stock Exchange ,
Kelun Pharmaceutical ,
Merck Sharp ,
China Merchants Capital ,
Southeast China ,
Kulun Biotech ,
Hillhouse Capital ,
Lilly Asia Ventures ,
Suzhou Likang Investment ,
Zhuhai Liangheng Investment ,